mdxhealth
Edit

mdxhealth

https://mdxhealth.com/
Last activity: 12.03.2024
Categories: ITManagementMedtechOptimizeProductCareDiagnosticsDoctorHealthTechInformation
MDxHealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The Company's European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and US headquarters and laboratory operations based in Irvine, California. MDxHealth is a publicly-listed company trading on the NYSE Euronext (NYSE as in New York Stock Exchange) markets of Brussels and Amsterdam under the ticker symbol "MDXH". MDxHealth develops molecular diagnostic products on its own or in partnership with pharmaceutical companies. Some of its products are already commercialized and the company has a broad pipeline of other products for major cancer indications.
Likes
1.87K
Followers
5.45K
Mentions
52
Location: Sierra Leone, Western Area, Freetown
Employees: 51-200
Phone: +1 866-259-5644
Total raised: $38.1M
Founded date: 2003

Investors 5

Funding Rounds 2

DateSeriesAmountInvestors
02.02.2023-$37M-
03.05.2011Grant$1.1M-

Mentions in press and media 52

DateTitleDescriptionSource
12.03.2024Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Pr...Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering IRVINE, CA, and H...einpresswi...
06.03.2024Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financ...-globenewsw...
23.02.2024MMI Revolutionizes Microsurgery with $110 Million Series C F...MMI, a trailblazer in microsurgery robotics, secures a record-breaking $110 million in Series C fina...parsers.vc...
21.02.2024MMI Raises $110 Million in Series C FinancingThe funds will support commercialization of the Symani® Surgical System in high-growth markets and c...anderapart...
12.02.2024Internship Offer – Andera Life SciencesAndera Life Sciences, part of Andera Partners, is one of the leading Life Sciences venture capital t...anderapart...
27.11.2023MDxHealth annonce la réalisation de l'échange obligatoire d'...COMMUNIQUÉ DE PRESSE - INFORMATION RÉGLEMENTÉE 27 NOVEMBRE 2023, 1:00 EDT / 7:00 CET MDxHealth annon...einpresswi...
14.11.2023MDxHealth to Participate in the 35th Annual Piper Sandler He...NEWS RELEASE November 14, 2023, 4PM ET/ 22:00 CET MDxHealth to Participate in the 35th Annual Piper ...einpresswi...
10.08.2023MDxHealth to Present Q2 and Half Year 2023 Financial Results...NEWS RELEASE 10 AUGUST 2023, 4PM ET / 22:00 CET MDxHealth to Present Q2 and Half Year 2023 Financial...einpresswi...
09.08.2023Cigna Expands Commercial and Medicare Advantage Coverage to ...NEWS RELEASE 9 AUGUST 2023, 4PM ET / 22:00 CET Cigna Expands Commercial and Medicare Advantage Cover...einpresswi...
19.04.2023Foundational LCD couvre Select mdx pour le cancer de la pros.../EIN News/ -- COMMUNIQUÉ DE PRESSE - INFORMATION PRIVILÉGIÉE 19 AVRIL 2023, 16h00 EDT/22h00 CET IRVI...einpresswi...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In